Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily K member 3 (TASK-1, encoded by the KCNK3 gene) is a member of the two-pore-domain potassium (K2P) channel family. It functions as an outwardly rectifying background or leak potassium channel that is highly sensitive to extracellular pH, hypoxia, and anesthetic agents. TASK-1 plays a critical role in stabilizing the resting membrane potential and regulating cellular excitability in various tissues, including atrial cardiomyocytes, pulmonary artery smooth muscle cells, and central neurons.
In disease states, upregulation of TASK-1 in atrial fibrillation leads to action potential duration shortening, making its inhibition a promising strategy for rhythm control. Conversely, loss-of-function mutations or downregulation of KCNK3 are strongly linked to the pathogenesis of pulmonary arterial hypertension (PAH) due to increased vasoconstriction and vascular remodeling. Pharmacological modulators of TASK-1 include inhibitors like doxapram and the investigational compound BAY 2586116, which are being evaluated for atrial fibrillation and obstructive sleep apnea, respectively. However, therapeutic targeting of TASK-1 requires careful management of safety concerns, particularly the risk of inducing pulmonary hypertension or systemic blood pressure elevation upon chronic channel blockade.
Inhibition of background potassium currents to prolong action potential duration and reduce cellular excitability (for atrial fibrillation and sleep apnea), or activation of the channel to hyperpolarize cells and induce vasodilation (for pulmonary arterial hypertension).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily K member 3 (TASK-1) (TASK-1).